Cargando…

Network Pharmacology-Based Mechanistic Investigation of Jinshui Huanxian Formula Acting on Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic respiratory disease with high incidence, morbidity, and mortality rates. Jinshui Huanxian formula (JHF) is an empirical formula that targets the pathogenesis of lung-kidney qi deficiency and phlegm-blood stasis in pulmonary fibrosis (PF). The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tiantian, Xu, Pengli, Qi, Shuishui, Ke, Shaorui, Hu, Qin, Zhao, Peng, Li, Jiansheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279870/ https://www.ncbi.nlm.nih.gov/pubmed/34306156 http://dx.doi.org/10.1155/2021/8634705

Ejemplares similares

Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology
por: Yuan, Jie, et al.
Publicado: (2022)

A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
por: Zhang, Weiwei, et al.
Publicado: (2023)

Mechanistic Investigation of Xuebijing for Treatment of Paraquat-Induced Pulmonary Fibrosis by Metabolomics and Network Pharmacology
por: Wang, Tongtong, et al.
Publicado: (2021)

Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
por: Cha, Seung-Ick, et al.
Publicado: (2012)

Log interpretation method of resistivity low-contrast oil pays in Chang 8 tight sandstone of Huanxian area, Ordos Basin by support vector machine
por: Bai, Ze, et al.
Publicado: (2022)

Investigation of the Pharmacological Effect and Mechanism of Jinbei Oral Liquid in the Treatment of Idiopathic Pulmonary Fibrosis Using Network Pharmacology and Experimental Validation
por: Zhang, Aijun, et al.
Publicado: (2022)

Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis
por: Millan-Billi, Paloma, et al.
Publicado: (2018)

Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
por: Wang, Zihao, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective
por: Mai, Tu H., et al.
Publicado: (2023)

Model‐based Meta‐Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis
por: Chan, Phyllis, et al.
Publicado: (2017)

Pharmacological treatment of idiopathic pulmonary fibrosis: time to step out of the comfort zone?
por: Sgalla, Giacomo, et al.
Publicado: (2020)

Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis
por: Li, Xuanlin, et al.
Publicado: (2020)

Mechanistic Investigation of Curcuma Protection against Oral Submucous Fibrosis
por: Peng, Haiyan, et al.
Publicado: (2022)

Systematic Analysis Strategy Based on Network Pharmacology to Investigate the Potential Mechanism of Fritillaria thunbergii Miq. against Idiopathic Pulmonary Fibrosis
por: Xu, Gonghao, et al.
Publicado: (2022)

Network Pharmacology-Based Strategy to Investigate Pharmacological Mechanisms of Qiaoshao Formula for Treatment of Premature Ejaculation
por: Wang, Ming, et al.
Publicado: (2020)

Role of the CASZ1 transcription factor in tissue development and disease
por: Liu, Tiantian, et al.
Publicado: (2023)

Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I–induced kidney fibrosis through network pharmacology
por: Wang, Fan, et al.
Publicado: (2022)

A Network Pharmacology Approach to Explore the Potential Mechanisms of Yifei Sanjie Formula in Treating Pulmonary Fibrosis
por: Qiao, Bo, et al.
Publicado: (2020)

Investigation on the Mechanism of Qubi Formula in Treating Psoriasis Based on Network Pharmacology
por: Zhou, Lin, et al.
Publicado: (2020)

Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease
por: Li, Jiansheng, et al.
Publicado: (2015)

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
por: Kreuter, Michael, et al.
Publicado: (2015)

A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
por: Fan, Chang, et al.
Publicado: (2020)

The Influence of BuqiHuoxueTongluo Formula on Histopathology and Pulmonary Function Test in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats
por: Yu, Xiaolin, et al.
Publicado: (2018)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic
por: Serra López-Matencio, José M., et al.
Publicado: (2021)

Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis
por: Yang, Haojie, et al.
Publicado: (2019)

Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
por: Hou, Yuan, et al.
Publicado: (2023)

Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs
por: Zhang, Zhenzhen, et al.
Publicado: (2023)

A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2
por: Bai, Yunping, et al.
Publicado: (2018)

Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation
por: Heinz, Sabrina, et al.
Publicado: (2017)

Sleep Apnea in Idiopathic Pulmonary Fibrosis: A Molecular Investigation in an Experimental Model of Fibrosis and Intermittent Hypoxia
por: Haine, Liasmine, et al.
Publicado: (2021)

Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
por: Huang, Jiansheng, et al.
Publicado: (2020)

Mechanistic Insights into the Pharmacological Significance of Silymarin
por: Wadhwa, Karan, et al.
Publicado: (2022)

Mechanism of Fei-Xian Formula in the Treatment of Pulmonary Fibrosis on the Basis of Network Pharmacology Analysis Combined with Molecular Docking Validation
por: Chen, Xiao-Li, et al.
Publicado: (2021)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Epidemiology of idiopathic pulmonary fibrosis
por: Ley, Brett, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f7c4ri60kl9ivavpctdrhd99bd